Provided by Tiger Trade Technology Pte. Ltd.

Sub-New Stocks

337.986
0.000
Number of Gainers:4
Number of Losers:7
Number of Flat:48
PE:- -
High:337.986
Open:337.986
Low:337.986
Close:337.986
Volume:- -
Turnover:- -
Market Cap:803.35B
Float Cap:698.17B

Loading ...

Chaoju Eye Care Says Non-Executive Director Zhang Li Resigns

Reuters
·
Aug 28

Chaoju Eye Care Holdings H1 Revenue RMB 710.7 Million

THOMSON REUTERS
·
Aug 28

Mixue Likely to Face Headwinds

Dow Jones
·
Aug 28

Mixue Shares Extend Slide After Profit Decline

Dow Jones
·
Aug 28

CLSA Reaffirms Outperform on Bilibili, Trims Target Price as Ad Growth Stays Strong

Stock News
·
Aug 28

Hutchmed (China) Announces NMPA Conditional Approval for ATLED in China

Reuters
·
Aug 28

HUTCHMED's Cholangiocarcinoma Drug Application Gets Conditional Nod in China

MT Newswires Live
·
Aug 28

Hutchmed (China) - Fanregratinib to be Marketed in China as Atled

THOMSON REUTERS
·
Aug 28

Morimatsu International Holdings (SEHK:2155) Reports A Half Year Loss, Is The Stock Cheap?

Simply Wall St.
·
Aug 28

New Hope Service Reports Interim Results with 17% Profit Dip

Stock News
·
Aug 28

China's New Hope Service H1 Profit Falls 17%

Reuters
·
Aug 28

New Hope Service - ‍Interim Dividend of Hk$0.096 Per Share​

THOMSON REUTERS
·
Aug 28

New Hope Service Holdings H1 Revenue RMB 771.1 Million

THOMSON REUTERS
·
Aug 28

New Hope Service FY26 Interim Profit Attributable to Shareholders Falls 17% to RMB 100.4 Million; Revenue Rises 4.2% to RMB 771.1 Million

Reuters
·
Aug 28

Bilibili Hong Kong Shares Climb Most in 4 Weeks on Q2 Profit Growth

Reuters
·
Aug 28

CMB International Cuts Li Auto-W Price Target to HK$47, Maintains 'Hold' Rating

Stock News
·
Aug 28

Hong Kong Market Movers: Mixue's Revenue Reaches RMB 15.2 Billion in First Half, Global Store Network Expands

Stock News
·
Aug 28

HUTCHMED secures NMPA approval for ATLED to address FGFR2-altered intrahepatic cholangiocarcinoma

Stock News
·
Aug 28

Hutchmed (China) - Announces Nmpa Conditional Approval for Atled (Fantegratinib) in China

THOMSON REUTERS
·
Aug 28

Hutchmed Says China NMPA Approves ATLED for FGFR2-Altered Intrahepatic Cholangiocarcinoma

Reuters
·
Aug 28